Yuksel Filik
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil Activation.
Journal: Current allergy and asthma reports
Published: October 05, 2025
BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL.
Journal: American journal of hematology
Published: January 30, 2024
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.
Journal: Cancers
Published: December 31, 2021
PI3-kinase inhibition as a strategy to suppress the leukemic stem cell niche in Ph+ chronic myeloid leukemia.
Journal: American journal of cancer research
Published: August 05, 2021
Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations.
Journal: American journal of cancer research
Published: March 30, 2021
Cell-based and antibody-mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues.
Journal: Stem cells translational medicine
Published: April 08, 2020
STAT5 is Expressed in CD34+/CD38- Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.
Journal: Cancers
Published: April 03, 2020
The unfolded protein response impacts melanoma progression by enhancing FGF expression and can be antagonized by a chemical chaperone.
Journal: Scientific reports
Published: July 19, 2017
The unfolded protein response is a negative regulator of scavenger receptor class B, type I (SR-BI) expression.
Journal: Biochemical and biophysical research communications
Published: September 06, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026